Romano Kelly A SEC Filing Summary

Kelly A. Romano, a director at LeonaBio, Inc. (LONA), was granted 28,000 stock options on April 9, 2026. These options have an exercise price of $9.54 and are set to expire on April 8, 2036. The options are subject to a 24-month vesting schedule, with shares vesting monthly, contingent upon continued service as a provider. The filing also notes that these options were acquired with a transaction code "A" for acquired, with a transaction price of $0.0. Following the transaction, Romano holds 28,000 shares.